Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance

Novo Nordisk · Phase 3 · Completed · Enrollment 422

NCT00781937

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

X axis: threshold category. Y axis: participants reaching threshold, %.

50.521.9
≥5%
26.16.3
≥10%
≥15%
≥20%
Show as table
Arm≥5%≥10%≥15%≥20%
Lira 3.0 mg50.5%26.1%n/rn/r
Placebo21.9%6.3%n/rn/r

Not shown

Every selected arm is drawn.